Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_226bfbdd9ee7b4dd881f3b5c0e6a3994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18322 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
filingDate |
2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac5b9543898a96c1d072f8660bec15e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c56ff308f376a07f526108316ad246d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff60bf4d9f8ec109051e70191911ed38 |
publicationDate |
2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210126075-A |
titleOfInvention |
Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use |
abstract |
The present disclosure relates to chimeric respiratory syncytial viruses encoding chimeric RSV and hMPV F proteins and the use of chimeric viruses or components therein in vaccines. In certain embodiments, the present disclosure relates to live attenuated vaccines comprising a chimeric RSV and an RSV backbone replacing the hMPV F protein with the F protein of RSV. |
priorityDate |
2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |